Omandam, Rodrigo C.

HRN: 14-53-07  Sex: Male

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
05/07/2026
CLINDAMYCIN 150MG/ML, 4ML (AMP)
05/07/2026
05/14/2026
IV
600mg
Q6
Bullae
Checking Initial Appropriateness 

 Indication:  Empiric    Type of Infection:  Skin & Soft Tissue    Compliance to guidelines: Compliant To Guidelines